FA
TFFP

Fermata Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Fermata Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-961
Closed -$8.41K – 197
2023
Q3 		$8.41K Buy
+961
New +$9K ﹤0.01% 163
2023
Q1 		– Sell
-1,142
Closed -$30K – 143
2022
Q4 		$30K Buy
1,142
+30
+3% +$1.42K 0.01% 136
2022
Q3 		$113K Buy
1,112
+8
+0.7% +$1.08K 0.04% 130
2022
Q2 		$156K Buy
1,104
+150
+16% +$20.9K 0.05% 157
2022
Q1 		$150K Buy
954
+57
+6% +$9.21K 0.06% 182
2021
Q4 		$199K Buy
897
+74
+9% +$14.3K 0.07% 183
2021
Q3 		$159K Buy
823
+7
+0.9% +$1.49K 0.07% 174
2021
Q2 		$196K Buy
816
+308
+61% +$84.5K 0.11% 153
2021
Q1 		$167K Buy
+508
New +$207K 0.14% 70

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Fermata Advisors's TFFP Position: Q4 2023 in Review

Fermata Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 961 shares — an estimated $8.41K sold.

Fermata Advisors first reported a position in TFFP in Q1 2021 and held it in 9 quarters. The position peaked at $199K in Q4 2021. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Fermata Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Fermata Advisors sold 961 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $8.41K.
  • Fermata Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Fermata Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $199K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Fermata Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.